Glossary of peptide terminology: difference between revisions
Diff·revision 3 → 4·23:34, 22 Aug 2024
Difference between revision 3 and revision 4 of Glossary of peptide terminology. 3 lines changed; the page grew by 238 bytes.
| Revision 3 — 13:57, 29 Jul 2024 LedeLeander (talk) expand §Clinical and evidence 2,033 bytes ±0 | Revision 4 — 23:34, 22 Aug 2024 SerialCommaSeb (talk) add the missing entry to the list 2,271 bytes +238 | ||
|---|---|---|---|
| 9 | Definitions here are deliberately brief. Where a term carries a distinction that matters — purity against content, sterility against endotoxin freedom, contraindication against warning — the entry states the distinction and the article develops it.{{r|usp621}} | 9 | Definitions here are deliberately brief. Where a term carries a distinction that matters — purity against content, sterility against endotoxin freedom, contraindication against warning — the entry states the distinction and the article develops it.{{r|usp621}} |
| 10 | 10 | ||
| + | 11 | The glossary is not a substitute for the articles and does not attempt completeness.{{r|reports}} | |
| + | 12 | ||
| 11 | == Chemistry and manufacture == | 13 | == Chemistry and manufacture == |
| 12 | ; Aib : α-aminoisobutyric acid, a non-proteinogenic residue used to block [[Dipeptidyl peptidase-4|DPP-4]] cleavage. | 14 | ; Aib : α-aminoisobutyric acid, a non-proteinogenic residue used to block [[Dipeptidyl peptidase-4|DPP-4]] cleavage. |
| ⋮ | ⋮ | ||
| 24 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 26 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| 25 | <ref name="usp621">United States Pharmacopeia, General Chapter <621>, ''Chromatography''.</ref> | 27 | <ref name="usp621">United States Pharmacopeia, General Chapter <621>, ''Chromatography''.</ref> |
| + | 28 | <ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref> | |
| 26 | 29 | ||
| 27 | {{DEFAULTSORT:Glossary of peptide terminology}} | 30 | {{DEFAULTSORT:Glossary of peptide terminology}} |